Published in
American Society of Clinical Oncology, Journal of Clinical Oncology, 15_suppl(34), p. 2580-2580
DOI: 10.1200/jco.2016.34.15_suppl.2580
Links
Tools
Investigational NEDD8-activating enzyme inhibitor pevonedistat (Pev) plus chemotherapy in patients (Pts) with solid tumors (Phase 1b study): Antitumor activity of pev plus carboplatin (Carbo)/paclitaxel (Pac).
Journal article published in 2016 by
Todd Michael Bauer,
R. Donald Harvey 
,
Carrie B. Lee,
Charu Aggarwal,
Roger B. Cohen,
Farhad Sedarati,
Zhaoyang Teng,
Hélène M. Faessel,
Ajeeta Dash,
Sergio Santillana,
Bruce J. Dezube,
Afshin Dowlati,
Albert C. Lockhart
,
Carrie B. Lee,
Charu Aggarwal,
Roger B. Cohen,
Farhad Sedarati,
Zhaoyang Teng,
Hélène M. Faessel,
Ajeeta Dash,
Sergio Santillana,
Bruce J. Dezube,
Afshin Dowlati,
Albert C. Lockhart
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 